Skip to main content
Clinical Trials/NCT02303691
NCT02303691
Completed
Not Applicable

Neural Dimensions of Attention Bias Modification for Transdiagnostic Anxiety

University of Pittsburgh1 site in 1 country70 target enrollmentApril 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anxiety
Sponsor
University of Pittsburgh
Enrollment
70
Locations
1
Primary Endpoint
CAPS--Hypervigilance item
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This project seeks to identify neural mechanisms underlying the tendency for anxious individuals to pay more attention to threatening information than to other types of information. A computerized treatment designed to train individuals to reduce their attention towards threat will be tested, with a focus on understanding the aspects of brain function that predict response to the treatment. This work could ultimately lead to the ability to treat anxiety more effectively by directly targeting the aspects of brain function that are altered in a given patient.

Registry
clinicaltrials.gov
Start Date
April 2013
End Date
January 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rebecca Price

PhD

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • Participants will:
  • be between the ages of 18 and 55 years,
  • score \>45 on the Spielberger State-Trait Anxiety Inventory-trait form.
  • score \>=75th percentile on the World Health Organization Disability Assessment Schedule 2.0

Exclusion Criteria

  • Current medication or Cognitive-Behavioral Therapy for anxiety or depression;
  • Failure to meet standard Magnetic Resonance Imaging (MRI) inclusion criteria: those who have cardiac pacemakers, neural pacemakers, surgical clips in the brain or blood vessels, surgically implanted metal plates, screws or pins, cochlear implants, Intrauterine Devices, metal braces, or other metal objects in their body, especially in the eye. If the subject has any metal or implants in the body they must be deemed safe by the MRI Research Center's safety screening procedure prior to enrollment. Dental fillings do not present a problem. Plastic or removable dental appliances do not require exclusion. Pregnancy, determined by pregnancy tests on females.
  • currently suicidal or at risk for harm to self or others,
  • visual disturbance (\<20/40 as per the Snellen test, corrective lenses allowed)
  • \<6th grade reading level as per the Wide Range Achievement Test
  • presence of bipolar, psychotic, autism spectrum, substance dependence, or primary depressive disorder
  • positive urine drug test

Outcomes

Primary Outcomes

CAPS--Hypervigilance item

Time Frame: 1 month

Secondary Outcomes

  • Mood and Anxiety Symptoms Questionnaire(1 month)
  • Mini International Neuropsychiatric Interview (MINI)(1 month)
  • Attentional bias towards threat (Performance-based assessment of attentional bias towards threat based on reaction times and eye tracking)(immediate)
  • Liebowitz Social Anxiety Scale(1 month)
  • World Health Organization Disability Assessment Scale (WHODAS)(1 month)
  • Speilberger State-Trait Anxiety Inventory(1 month)
  • Beck Anxiety Inventory(1 month)
  • Penn State Worry Questionnaire(1 month)

Study Sites (1)

Loading locations...

Similar Trials